BAM
Bellevue Asset Management’s CVS Health CVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.9K | Hold |
100
| – | – | ﹤0.01% | 309 |
|
|
2025
Q1 | $6.78K | Hold |
100
| – | – | ﹤0.01% | 302 |
|
|
2024
Q4 | $4.49K | Sell |
100
-112
| -53% | -$5.03K | ﹤0.01% | 357 |
|
|
2024
Q3 | $13.4K | Buy |
212
+1
| +0.5% | +$63 | 0.01% | 258 |
|
|
2024
Q2 | $12.5K | Sell |
211
-595
| -74% | -$35.2K | 0.01% | 258 |
|
|
2024
Q1 | $64.3K | Buy |
806
+1
| +0.1% | +$80 | 0.04% | 123 |
|
|
2023
Q4 | $63.6K | Buy |
805
+1
| +0.1% | +$79 | 0.06% | 126 |
|
|
2023
Q3 | $56.1K | Buy |
804
+1
| +0.1% | +$70 | 0.04% | 128 |
|
|
2023
Q2 | $55.5K | Buy |
803
+1
| +0.1% | +$69 | 0.03% | 133 |
|
|
2023
Q1 | $59.6K | Sell |
802
-203
| -20% | -$15.1K | 0.04% | 130 |
|
|
2022
Q4 | $93.1K | Hold |
1,005
| – | – | 0.07% | 97 |
|
|
2022
Q3 | $98K | Buy |
1,005
+1
| +0.1% | +$98 | 0.08% | 98 |
|
|
2022
Q2 | $93K | Buy |
1,004
+1
| +0.1% | +$93 | 0.07% | 102 |
|
|
2022
Q1 | $102K | Hold |
1,003
| – | – | 0.06% | 106 |
|
|
2021
Q4 | $104K | Buy |
1,003
+1
| +0.1% | +$104 | 0.06% | 115 |
|
|
2021
Q3 | $86K | Hold |
1,002
| – | – | 0.05% | 127 |
|
|
2021
Q2 | $84K | Sell |
1,002
-251
| -20% | -$21K | 0.05% | 136 |
|
|
2021
Q1 | $95K | Hold |
1,253
| – | – | 0.06% | 121 |
|
|
2020
Q4 | $92K | Buy |
1,253
+1
| +0.1% | +$73 | 0.06% | 120 |
|
|
2020
Q3 | $73K | Buy |
1,252
+180
| +17% | +$10.5K | 0.05% | 127 |
|
|
2020
Q2 | $70K | Sell |
1,072
-28
| -3% | -$1.83K | 0.07% | 129 |
|
|
2020
Q1 | $70K | Buy |
1,100
+200
| +22% | +$12.7K | 0.07% | 128 |
|
|
2019
Q4 | $67K | Buy |
+900
| New | +$67K | 0.05% | 125 |
|